Dr. Falk PharmaFalk Foundation
  • About us
    About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Partnering
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence
  • Events
    Events
    • Falk Forums
    • Falk Futures
    • Symposia
  • Falk Foundation Awards
    Falk Foundation Awards
    • Falk Foundation / Guts UK Awards
    • Falk Foundation Awards Ireland
    • Falk Foundation / BASL Awards
  • Product Overview
    Product Overview
    • Budenofalk®
    • Jorveza®
    • Salofalk®
    • Ursofalk®
  • Healthcare Professionals
    Healthcare Professionals
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Falk News
    • Our Apps
    • FalkPlus
    • Resources
  • Patient Support
    Patient Support
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Patient Apps
  • Falk+
Search
Please choose your country
  • Global (English)
  • Australia
  • België (Vlaams)
  • Belgique (Français)
  • Deutschland
  • España
  • France
  • Ireland
  • Italia
  • Luxembourg (Français)
  • Nederland
  • Österreich
  • Portugal
  • Россия
  • Schweiz (Deutsch)
  • Suisse (Français)
  • United Kingdom
more info

Contact:
Phone:+44 (0)1628 536600 Email: office@drfalkpharma.co.uk

  • Contact
  • Newsroom
  • Our Partnerships
  • Falk Foundation
  • Reporting misconduct
  • Declaration
  • Reporting Adverse Events
  • Basket
  • My Account
  • Follow us on X
  • Follow us on Linkedin
Login
  • About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Partnering
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence
  • Events
    • Falk Forums
    • Falk Futures
    • Symposia
  • Falk Foundation Awards
    • Falk Foundation / Guts UK Awards
    • Falk Foundation Awards Ireland
    • Falk Foundation / BASL Awards
  • Product Overview
    • Budenofalk®
    • Jorveza®
    • Salofalk®
    • Ursofalk®
  • Healthcare Professionals
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Falk News
    • Our Apps
    • FalkPlus
    • Resources
  • Patient Support
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Patient Apps
  • Falk+
  • Contact
  • Newsroom
  • Our Partnerships
  • Falk Foundation
  • Reporting misconduct
  • Declaration
  • Reporting Adverse Events
  • Basket
  • My Account
  • Follow us on X
  • Follow us on Linkedin
Contact:
Phone:
+44 (0)1628 536600
Email:
office[at]drfalkpharma.co.uk
  • Homepage
  • Search

Search results

189 results

  • Privacy Policy
    Data Privacy Homepage Privacy Policy Dr. Falk Pharma UK Ltd Website Cookies and Privacy Policy Dr Falk Pharma UK Ltd (Dr Falk) respects the privacy of visitors to its websites (the ‘Sites’) and is…
  • Contact
    Contact us Homepage Contact Thank you for your interest in our company. If you have any questions or suggestions please do not hesitate to contact us. We will be happy to connect you with the person…
  • Basket
    Basket Homepage Basket
  • NEWSROOM
    Strategic Partnership with Allianthera (Suzhou) Biopharmaceuticals
    for Novel AhR Agonist Development for the Treatment of Moderate to Severe Ulcerative Colitis
  • Resources
    IBD Laboratory Diagnostics S43e Falk Foundation
    QR code
  • Resources
    EoE MDT
  • Resources
    EoE Master Slide Set
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • »
Falk Foundation

Discover the range of continuing education opportunities for physicians and pharmacists provided by the Falk Foundation e.V.

Dr. Falk Pharma UK

Dr. Falk Pharma is the expert in digestive and metabolic medicine. As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being.

  • About us
  • Events
  • Contact
  • Reporting misconduct
  • Basket
  • Products
  • Patients
  • Social Media Community Guidelines
  • Reporting Adverse Events
© 2026 Dr. Falk Pharma UK Ltd | Company Registration Number: 2307698
  • Privacy Policy
  • Terms & Conditions
Notice

This website is an international information resource intended for healthcare professionals outside the United States (US) and United Kingdom (UK).

I am a health care professional outside the US and UK.

Accept
UK Login
Notice
I confirm I am a UK or Irish resident and have been prescribed either Budenofalk®, Jorveza®, Salofalk® or Ursofalk®
Accept

You are now leaving uk.drfalkpharma.com for an external website.

Dr Falk Pharma UK accepts no responsibility for the content of other websites.